CD8A and cancer: For example, it has been found that neoantigen-reactive CD8+ T cells are also those that are positive for PD-1, not only suggesting the possibility of utilizing these tumor-reactive T cells for future neoantigen identification, but also for elucidating the immunological mechanisms in which cancer cell tolerance still results despite appropriate neoantigen recognition.